The Wall Street Journal: Pfizer Nears Deal to Combine off-Patent Drug Business With Mylan ForexTV.com
Pfizer Inc. is in talks to merge its off-patent drugs business with generic drugmaker Mylan NV, according to people familiar with the matter, in a deal that would …